Sanofi plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining ...

Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their ...

(Reuters) -French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through ...

Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job ...

Chinese Vice Premier He Lipeng began talks with U.S. Treasury Secretary Scott Bessent early on Saturday in Geneva in a ...

Sanofi (SNY) commits $20B to U.S. research & manufacturing by 2030, boosting R&D & partnerships amidst industry-wide ...

Add Sanofi to the list of drugmakers committing billions to bolster their operations in the United States as President Donald ...

Sanofi India's EBITDA rose 25% to ₹171.9 crore in Q4, with margins improving to 32.1%. Shares closed 2.3% higher at ₹6,066.55 ...

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

The latest health news highlights Sanofi's $20 billion U.S. investment through 2030, Merck's cancer drug expansion and the ...

The American Academy of Pediatrics has said childhood vaccines are carefully studied in randomized controlled trials — ...